Author/Creator: Menter, Alan - British Library Electronic Legal Deposit Catalogue-Journal Issues and Articles Search Results

Author/Creator Menter, Alan

1. A randomized, double-blind, placebo-controlled, dose-escalation study of the safety and efficacy of INCB039110, an oral janus kinase 1 inhibitor, in patients with stable, chronic plaque psoriasis. (3rd July 2016)

Authors:: Bissonnette, Robert; Luchi, Monica; Fidelus-Gort, Rosanne; Jackson, Shawnta; Zhang, Haifeng; Flores, Robert; Newton, Robert; Scherle, Peggy; Yeleswaram, Swamy; Chen, Xuejun; Menter, Alan
Journal:: Journal of dermatological treatment
Issue:: Volume 27:Number 4(2016:Aug.)
Page Start:: 332
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

2. A review article on brodalumab in the treatment of moderate-to-severe plaque psoriasis. (September 2017)

Authors:: Roostaeyan, Omid; Kivelevitch, Dario; Menter, Alan
Journal:: Immunotherapy
Issue:: Volume 9:Number 12(2017)
Page Start:: 963
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

3. A Review of Biologic Therapies Targeting IL-23 and IL-17 for Use in Moderate-to-Severe Plaque Psoriasis. Issue 1 (March 2016)

Authors:: Campa, Molly; Mansouri, Bobbak; Warren, Richard; Menter, Alan
Journal:: Dermatology and therapy
Issue:: Volume 6:Issue 1(2016)
Page Start:: 1
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

4. A Review of Biologic Therapies Targeting IL-23 and IL-17 for Use in Moderate-to-Severe Plaque Psoriasis. Issue 1 (March 2016)

Authors:: Campa, Molly; Mansouri, Bobbak; Warren, Richard; Menter, Alan
Journal:: Dermatology and therapy
Issue:: Volume 6:Issue 1(2016)
Page Start:: 1
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

5. A review of emerging IL-17 inhibitors in the treatment of psoriasis focusing on preclinical through phase II studies. (1st November 2016)

Authors:: Campa, Molly; Menter, Alan
Journal:: Expert opinion on investigational drugs
Issue:: Volume 25:Number 11(2016:Nov.)
Page Start:: 1337
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

6. Adalimumab in paediatric psoriasis. Issue 10089 (1st July 2017)

Authors:: Kivelevitch, Dario; Menter, Alan
Journal:: Lancet
Issue:: Volume 390:Issue 10089(2017)
Page Start:: 5
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

7. Anti-IL17 therapies for psoriasis. (2nd January 2019)

Authors:: Silfvast-Kaiser, Annika; Paek, So Yeon; Menter, Alan
Journal:: Expert opinion on biological therapy
Issue:: Volume 19:Number 1(2019)
Page Start:: 45
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

8. Anti‐IL‐23 and Anti‐IL‐17 Biologic Agents for the Treatment of Immune‐Mediated Inflammatory Conditions. Issue 1 (19th October 2017)

Authors:: Frieder, Jillian; Kivelevitch, Dario; Haugh, Isabel; Watson, Ian; Menter, Alan
Journal:: Clinical pharmacology & therapeutics
Issue:: Volume 103:Issue 1(2018)
Page Start:: 88
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

9. Are drug treatments for psoriasis a cardiovascular risk?. (January 2012)

Authors:: Ryan, Caitriona; Patel, Mahir; Menter, Alan
Journal:: Clinical practice
Issue:: Volume 9:Number 1(2012)
Page Start:: 5
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

10. Biological therapies for psoriasis. (December 2013)

Authors:: Mansouri, Bobbak; Patel, Mahir; Menter, Alan
Journal:: Expert opinion on biological therapy
Issue:: Volume 13:Number 12(2013:Dec.)
Page Start:: 1715
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗